Initial treatment outcomes of visceral leishmaniasis and HIV co-infected patients treated with a combination of liposomal amphotericin B (AmBisome) and miltefosine by MSF in Ethiopia from January 2011 to August 2014, by visceral leishmaniasis treatment history (N = 173).

Initial treatment outcomes of visceral leishmaniasis and HIV co-infected patients treated with a combination of liposomal amphotericin B (AmBisome) and miltefosine by MSF in Ethiopia from January 2011 to August 2014, by visceral leishmaniasis treatment history (N = 173).

本数据集涵盖2011年1月至2014年8月期间，无国界医生（Médecins Sans Frontières，MSF）在埃塞俄比亚开展的临床研究数据：针对接受脂质体两性霉素B（liposomal amphotericin B，AmBisome）联合米替福辛（miltefosine）治疗的HIV合并内脏利什曼病（visceral leishmaniasis）患者，按其内脏利什曼病治疗史分组分析其初始治疗结局，共纳入173例受试者（N=173）。